BIIB - Biogen

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, Apr 9, 2016.

  1. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    731
    Likes Received:
    489
    Biogen Alzheimer's Filing Begins Months-Long FDA Process -- Market Talk
    10:54 am ET July 8, 2020 (Dow Jones) Print



    10:54 ET - The FDA approval process isn't usually watched so closely, but in the case of Biogen's aducanumab--the company's potential blockbuster Alzheimer's drug--each incremental step is a milestone. Biogen gains 5% after submitting an approval application to FDA, and the regulator now has two months to declare whether it will accept the filing and kick off another months-long review process before an approval decision sometime next year. If FDA accepts the fling, shares could move even higher, says Leerink, which "still believe that the FDA wants to approve this drug in early Alzheimer's," despite controversial data backing its effectiveness. R.W. Baird sees "review acceptance as likely but believe the application falls woefully short of being approvable," and predicts the FDA will ultimately reject the drug. ([email protected])



    (END) Dow Jones Newswires

    July 08, 2020 10:54 ET (14:54 GMT)

    Copyright (c) 2020 Dow Jones & Company, Inc.
     
  2. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    731
    Likes Received:
    489
     
  3. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    731
    Likes Received:
    489
     
  4. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    731
    Likes Received:
    489
    every picture (chart) tells a story. [​IMG]
     
  5. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    What story is this one telling?
     
  6. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    731
    Likes Received:
    489
    here is today's story. would have to do some research to see what caused the november spike.

    ______

    January 29, 2021
    11:40 am ET
    Biogen shares jump 9% after FDA extends review period for Alzheimer's treatment
    MarketWatch
    11:40 am ET
    Biogen Shares Jump 9% After FDA Extends Review Period For Alzheimer's Treatment -- MarketWatch
    MarketWatch
    11:16 am ET
    Lilly Reports Strong Sales, Boosted by Covid Antibodies -- Barrons.com
    Dow Jones
    10:50 am ET
    FDA Extends Review of Biogen, Eisai's Alzheimer's Drug
    Dow Jones
    10:38 am ET
    The FDA Delayed Its Decision on Biogen's Alzheimer's Drug. The Stock Is Up 10%. -- Barrons.com
    Dow Jones
    10:10 am ET
    Murky Picture in the Biogen/Eisai/FDA Tea Leaves -- Market Talk
    Dow Jones
    9:15 am ET
    Biogen Shares Jump After FDA Delays Aducanumab Decision By 3 Months
    Benzinga
    7:48 am ET
    FDA Extends Review of Biogen, Eisai Alzheimer's Drug Candidate
    Dow Jones
    7:31 am ET
    *Biogen, Eisai Report FDA Extended Review Period By 3 Months For Biologics License Application For Aducanumab For Alzheimer's
    Benzinga
     
    T0rm3nted likes this.
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,539
    Likes Received:
    2,996
    Now this is what the old glory days of biotech used to look like! :D

    upload_2021-6-7_10-31-49.png
     
    T0rm3nted likes this.

Share This Page